Effects of quetiapine on gonadal axis hormones in male patients with schizophrenia: A preliminary, open study

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 5, 2003, Pages 875-878

  Kaneda, Yasuhiro ^a,b   Ohmori, Tetsuro ^b  

^a Psychiatric Hospital at Vanderbilt   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Anticholinergic; Hypothalamo pituitary gonadal (HPG) axis; Prolactin; Psychotic symptoms; Quetiapine

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BROMPERIDOL; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOSPIPRAMINE; ESTRADIOL; FLUPHENAZINE; FOLLITROPIN; HALOPERIDOL; LEVOMEPROMAZINE; LUTEINIZING HORMONE; NEUROLEPTIC AGENT; PIPAMPERONE; PROLACTIN; QUETIAPINE; SEX HORMONE; SULPIRIDE; TESTOSTERONE; TIMIPERONE; ZOTEPINE;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GYNECOMASTIA; HORMONE BLOOD LEVEL; HUMAN; HYPNOSIS; HYPOPHYSIS ADRENAL SYSTEM; MALE; OPEN STUDY; PROLACTIN BLOOD LEVEL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0041630902     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00121-0     Document Type: Article

References (21)

1. Aizenberg D., Modai I., Landa A., Gil-Ad I., Weizman A. Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine. J. Clin. Psychiatry. 62:2001;541-544.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. (DSM-IV). 4th ed. 1994;American Psychiatric Association, Washington, DC.
3. Arvanitis L.A., Miller B.G. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol. Psychiatry. 42:1997;233-246.
4. Brambilla F., Guerrini A., Guastalla A., Rovere C., Riggi F. Neuroendocrine effects of haloperidol therapy in chronic schizophrenia. Psychopharmacologia. 44:1975;17-22.
5. Brown W.A., Laughren T.P., Williams B. Differential effects of neuroleptic agents on the pituitary-gonadal axis in men. Arch. Gen. Psychiatry. 38:1981;1270-1272.
6. Dev V., Raniwalla J. Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf. 23:2000;295-307.
7. Ferrier I.N., Cotes P.M., Crow T.J., Johnstone E.C. Gonadotropin secretion abnormalities in chronic schizophrenia. Psychol. Med. 12:1982;263-273.
8. Geddes J., Freemantle N., Harrison P., Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 321:2000;1371-1376.
9. Inada T. Evaluation and Diagnosis of Drug-Induced Extrapyramidal Symptoms: Commentary on the DIEPSS and guide to its usage. (in Japanese):1996;Seiwa Pub. Tokyo.
10. Kaneda Y. Effects of risperidone on gonadal axis hormones in schizophrenia. Ann. Pharmacother. 35:2001;1523-1527.
11. Kaneda Y., Fujii A. Effects of chronic neuroleptic administration on the hypothalamo-pituitary-gonadal axis of male schizophrenics. Prog. Neuropsychopharmacol. Biol. Psychiatry. 24:2000;251-258.
12. Kaneda Y., Ohmori T. Quetiapine impact on quality of life in patients with schizophrenia. Ann. Pharmacother. 37:2003;917-918.
13. Kapur S., Langlois X., Vinken P., Megens A.A., De Coster R., Andrews J.S. The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats. J. Pharmacol. Exp. Ther. 302:2002;1129-1134.
14. Laumann E.O., Paik A., Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 281:1999;537-544.
15. Markianos M., Hatzimanolis J., Lykouras L. Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone. Psychopharmacology. 143:1999;270-272.
16. Markianos M., Hatzimanolis J., Lykouras L. Switch from neuroleptics to clozapine does not influence pituitary-gonadal axis hormone levels in male schizophrenic patients. Eur. Neuropsychopharmacol. 9:1999;533-536.
17. Martin-du Pan R., Baumann P., Magrini G., Felber J.P. Neuroendocrine effects of chronic neuroleptic therapy in male psychiatric patients. Psychoneuroendocrinology. 3:1978;245-252.
18. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 10:1962;799-812.
19. Rubin R.T. Prolactin and schizophrenia. Meltzer H.Y. Psychopharmacology: The Third Generation of Progress. 1987;803-808 Raven Press, New York.
20. Verhulst J., Schneidman B. Schizophrenia and sexual functioning. Hosp. Community Psychiatry. 32:1981;259-262.
21. Wirshing D.A., Pierre J.M., Marder S.R., Saunders C.S., Wirshing W.C. Sexual side effects of novel antipsychotic medications. Schizophr. Res. 56:2002;25-30.